5-Mar-2026
Azenta Acquires UK Biocentre to Expand European Biorepository
TipRanks (Wed, 4-Mar 9:50 AM ET)
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
PRNewswire (Wed, 4-Mar 9:11 AM ET)
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
PRNewswire (Tue, 24-Feb 4:05 PM ET)
PRNewswire (Mon, 9-Feb 4:05 PM ET)
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
PRNewswire (Wed, 4-Feb 6:30 AM ET)
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
PRNewswire (Wed, 21-Jan 4:05 PM ET)
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S. R.L.
PRNewswire (Mon, 29-Dec 8:00 AM ET)
Azenta Authorizes $250 Million Share Repurchase Program
PRNewswire (Wed, 10-Dec 12:43 PM ET)
Azenta's 2025 Results Highlight Expanding Margins and Strength in Multiomics Segment
Market Chameleon (Fri, 21-Nov 4:18 AM ET)
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
Azenta trades on the NASDAQ stock market under the symbol AZTA.
As of March 5, 2026, AZTA stock price declined to $24.79 with 550,999 million shares trading.
AZTA has a beta of 1.20, meaning it tends to be more sensitive to market movements. AZTA has a correlation of 0.13 to the broad based SPY ETF.
AZTA has a market cap of $1.14 billion. This is considered a Small Cap stock.
Last quarter Azenta reported $149 million in Revenue and $.09 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.03.
In the last 3 years, AZTA traded as high as $69.16 and as low as $23.77.
The top ETF exchange traded funds that AZTA belongs to (by Net Assets): IJR, VTI, VB, IWM, VBR.
AZTA has underperformed the market in the last year with a price return of -39.6% while the SPY ETF gained +19.4%. AZTA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -29.4% and -16.9%, respectively, while the SPY returned -0.2% and -0.7%, respectively.
AZTA support price is $24.30 and resistance is $25.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZTA shares will trade within this expected range on the day.
